Trending...
- Pacific Surfliner Service Temporarily Suspended South of Irvine Station
- Are Scary Movies Mentally Designed By The Horrific Environment Within Society: New Premiere Smile
- California Empowers Students
LOS ANGELES--(BUSINESS WIRE)--Respira Technologies, Inc.—a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases—has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira's founder, Mario Danek, will transition to the role of Chief Technology Officer.
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
- THINKWARE Announces Amazon Prime Fall Promotion
- Five New Members Join Ventura College Foundation Board
- One Park Technologies Fuel Its Growth in Texas
- Flutter vs. React Native — What to сhoose in 2021?
- General Micro Systems (GMS) Introduces Lightweight, Rugged, "X9 Spider Wearable" Mobile Computer with Eight I/O "Legs" and Optional AI GPGPU
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Filed Under: Business
0 Comments
Latest on The Californer
- Virgin Orbit's Next Rocket Ready for Cornwall
- idrive Offers Advanced System Updates for Its AI Dash Camera
- Prolific American Political Author Launches Legacy Books Website
- Bloom IVF Group rolls out Artificial Intelligence across its clinics in India, helping patients get pregnant sooner and for lower cost USA - English USA - English
- museLIVE - The Future of Web3 Live Music
- Promoting Homes To More Buyers For MORE Money
- California Distributed $1.4 Billion in Utility Bill Relief for 2.2 Million Households
- General Motors Hit With $102.6 Million Jury Verdict in Class Action Over Defective Engines
- The Latino Community Foundation to Host: 5-Year Wildfire Anniversary to Honor Grassroots Leadership & Unveil to Lift up its Revolutionizing Model for Disaster Philanthropy
- Four Day Int'l Wild Bunch Film Festival Event Hits The Galaxy Theatres In Tucson Oct 20-23
- Crypto.com Arena Opens Two New Grab and Go Locations Powered by Amazon's Just Walk Out Technology
- Provender Partners Acquires 483K-SF Food Related Industrial Portfolio for $29.9 Million
- San Francisco Secures Over $117 Million in State Funding for Affordable Housing
- Electives, Inc. Sets Stage for Long-Term Growth with Key Hires
- Waterside Productions Announces David M. Huffman's Book "Coming of Age in Yellowstone National Park"
- Colorado's Largest Witch Festival, "WitchFest", October 21-22
- New Smart Mouse uses Artificial Intelligence (AI) and Voice Recognition Technology to Improve Business Productivity
- GLASSDOOR APPOINTS DANNY GUILLORY AS CHIEF PEOPLE OFFICER
- One Mind at Work, Columbia University Mental Health + Work Design Lab, and Ethisphere announce the Mental Health at Work Index™, the first of its kind comprehensive strategy to not only measure but also improve and innovate workplace mental health
- Wastewater Facilities Turn to Greasezilla® for Upstream Fats, Oils & Grease Solution and Revenue Generation